Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: A subset of myositis associated with a favourable outcome

Rheumatology

Volumn 41, Issue 9, 2002, Pages 1040-1046

  Coppo, P ^c   Clauvel, J P ^c   Bengoufa, D ^a   Oksenhendler, E ^c   Lacroix, C ^b   Lassoued, K ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c NONE

Author keywords

Anti ribonucleoprotein antibodies; Autoantibodies; Inflammatory myositis

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN; METHOTREXATE; MUSCLE ANTIBODY; POLYCLONAL ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTHRITIS; ARTICLE; ASEPTIC NECROSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; INFLAMMATION; INTERSTITIAL LUNG DISEASE; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; NEGRO; NEOPLASM; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; RAYNAUD PHENOMENON; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCLEROSIS;

ADULT; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; DERMATOMYOSITIS; ELECTROMYOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RNA, SMALL NUCLEAR; TREATMENT OUTCOME;

EID: 0036736449     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Monoclonal antibody analysis of mononuclear cells in myopathies. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells
2. Clinical presentation and diagnosis of polymyositis and dermatomyositis
3. Inflammatory myopathies
4. Polymyositis and dermatomyositis
5. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
6. Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases
7. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets
8. Pathology of skeletal muscle in mixed connective tissue disease
9. Clinical aspects of myopathy in rheumatoid arthritis
10. Serum autoantibodies to the nucleolar antigen PM/Scl. Clinical and immunogenetic associations
11. High incidence of malignancies in patients with dermatomyositis and polymyositis: An 11-year analysis
12. Thymoma-associated dermatomyositis and polymyositis
13. Prognostic factors in polymyositis/dermatomyositis. A computer-associated analysis of ninety-two cases
14. Polymyositis-dermatomyositis: 25 years of follow-up of 50 patients disease course, treatment, prognostic factors
15. Cardiac involvement in polymyositis: A clinicopathologic study of 20 autopsied patients
16. Pulmonary disease in polymyositis/dermatomyositis
17. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl tRNA synthetases
18. Clinical course of idiopathic inflammatory myopathies: Complications, survival and prognostic factors
19. Myositis: Immunological aspects of etiology and pathogenesis
20. Multiplicity of antibodies in myositis sera
21. Autoantibodies associated with polymyositis and dermatomyositis
22. Autoantibodies in the diagnosis of systemic rheumatic diseases
23. Immunologic aspects of myositis
24. The Jo-1 antibody system in myositis: Relationships to clinical features and HLA
25. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease
26. Autoantibodies in inflammatory myopathies
27. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
28. The clinical and immunogenetic features of patients with antibodies to the nucleolar antigen PM/Scl
29. A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies
30. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen
31. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
32. Preliminary criteria for the classification of Sjogren's syndrome
33. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
34. Preliminary criteria for the classification of systemic sclerosis
35. Muscle disease in progressive systemic sclerosis
36. Détection des anticorps anti-ADN natif de classe IgG, IgA, et IgM par ELISA. Comparaison avec le test de Farr et l'immunofluorescence indirecte
37. Aminoacyl-t RNA (other than histidyl) synthetase autoantibodies
38. On the neuromyositis syndrome. Classification of neuromyositis based on 5 personal cases
39. Immunopathogenesis of inflammatory myopathies
40. Molecular immunology and genetics of inflammatory muscle diseases
41. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor
42. Dermatomyositis, polymyositis, and Coxsackie B virus infection
43. Cellular protein and RNA antigens in autoimmune disease
44. Purification and visualisation of native spliceosomes
45. Purification and characterization of human autoantibodies directed to specific regions on U1-RNA; recognition of native U1RNP complexes
46. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus
47. Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis
48. Long-term prognosis of 69 patients with dermatomyositis or polymyositis